SE0001128D0 - A method of producing IgG - Google Patents

A method of producing IgG

Info

Publication number
SE0001128D0
SE0001128D0 SE0001128A SE0001128A SE0001128D0 SE 0001128 D0 SE0001128 D0 SE 0001128D0 SE 0001128 A SE0001128 A SE 0001128A SE 0001128 A SE0001128 A SE 0001128A SE 0001128 D0 SE0001128 D0 SE 0001128D0
Authority
SE
Sweden
Prior art keywords
igg
igg fraction
iii
fraction
derived
Prior art date
Application number
SE0001128A
Other languages
English (en)
Swedish (sv)
Inventor
Lars-Olof Lindquist
Inger Andersson
Original Assignee
Amersham Pharm Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20279068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0001128(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Pharm Biotech Ab filed Critical Amersham Pharm Biotech Ab
Priority to SE0001128A priority Critical patent/SE0001128D0/xx
Publication of SE0001128D0 publication Critical patent/SE0001128D0/xx
Priority to PT01940271T priority patent/PT1268551E/pt
Priority to CA002402784A priority patent/CA2402784A1/fr
Priority to TR2004/00701T priority patent/TR200400701T4/xx
Priority to DE60102144T priority patent/DE60102144T2/de
Priority to CN01807338A priority patent/CN1419566A/zh
Priority to IL15166701A priority patent/IL151667A0/xx
Priority to RU2002124857/04A priority patent/RU2266914C2/ru
Priority to JP2001571775A priority patent/JP2003530326A/ja
Priority to BRPI0109740A priority patent/BRPI0109740B8/pt
Priority to AU2001273907A priority patent/AU2001273907B2/en
Priority to US10/220,929 priority patent/US6835379B2/en
Priority to PCT/EP2001/003624 priority patent/WO2001072844A2/fr
Priority to EP20010940271 priority patent/EP1268551B1/fr
Priority to AT01940271T priority patent/ATE260297T1/de
Priority to AU7390701A priority patent/AU7390701A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0001128A 2000-03-30 2000-03-30 A method of producing IgG SE0001128D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG
EP20010940271 EP1268551B1 (fr) 2000-03-30 2001-03-29 Procede de production d'igg
AT01940271T ATE260297T1 (de) 2000-03-30 2001-03-29 Eine methode zur herstellung von igg
CN01807338A CN1419566A (zh) 2000-03-30 2001-03-29 生产lgG的方法
JP2001571775A JP2003530326A (ja) 2000-03-30 2001-03-29 ＩｇＧを製造する方法
TR2004/00701T TR200400701T4 (tr) 2000-03-30 2001-03-29 lgG üretme yöntemi
DE60102144T DE60102144T2 (de) 2000-03-30 2001-03-29 EINE METHODE ZUR HERSTELLUNG VON IgG
PT01940271T PT1268551E (pt) 2000-03-30 2001-03-29 Metodo de producao de igg
IL15166701A IL151667A0 (en) 2000-03-30 2001-03-29 A METHOD OF PRODUCING IgG
RU2002124857/04A RU2266914C2 (ru) 2000-03-30 2001-03-29 Способ получения igg
CA002402784A CA2402784A1 (fr) 2000-03-30 2001-03-29 Procede de production d'igg
BRPI0109740A BRPI0109740B8 (pt) 2000-03-30 2001-03-29 método para produção de igg a partir de plasma para aplicações médicas
AU2001273907A AU2001273907B2 (en) 2000-03-30 2001-03-29 A method of producing IgG
US10/220,929 US6835379B2 (en) 2000-03-30 2001-03-29 Method of producing IgG
PCT/EP2001/003624 WO2001072844A2 (fr) 2000-03-30 2001-03-29 Procédé de production d'igg
AU7390701A AU7390701A (en) 2000-03-30 2001-04-02 A method of producing igg

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG

Publications (1)

Publication Number Publication Date
SE0001128D0 true SE0001128D0 (sv) 2000-03-30

Family

ID=20279068

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG

Country Status (15)

Country Link
US (1) US6835379B2 (fr)
EP (1) EP1268551B1 (fr)
JP (1) JP2003530326A (fr)
CN (1) CN1419566A (fr)
AT (1) ATE260297T1 (fr)
AU (2) AU2001273907B2 (fr)
BR (1) BRPI0109740B8 (fr)
CA (1) CA2402784A1 (fr)
DE (1) DE60102144T2 (fr)
IL (1) IL151667A0 (fr)
PT (1) PT1268551E (fr)
RU (1) RU2266914C2 (fr)
SE (1) SE0001128D0 (fr)
TR (1) TR200400701T4 (fr)
WO (1) WO2001072844A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451031C (zh) * 2003-09-05 2009-01-14 东丽株式会社 生物体成分组成改变了的溶液的调制方法
ATE540050T1 (de) * 2003-09-05 2012-01-15 Toray Industries Verfahren zur herstellung einer proteomanalyse- lösung
EP1532983A1 (fr) 2003-11-18 2005-05-25 ZLB Bioplasma AG Preparation d'immunoglobulines à stabilité élevée
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
CN100362022C (zh) * 2005-11-07 2008-01-16 中国人民解放军第二军医大学 海螵蛸多糖cps-1及其制备方法和用途
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
WO2007136327A1 (fr) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab Procédé de production d'igg
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
EA023382B1 (ru) 2009-05-27 2016-05-31 Бакстер Интернэшнл Инк. Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения
WO2011073235A1 (fr) 2009-12-18 2011-06-23 Csl Ltd. Procédé de purification de polypeptides
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (fr) 2010-02-26 2011-08-31 CSL Behring AG Préparation d'immunoglobuline et système de stockage pour préparation d'immunoglobuline
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
BR112014004445B1 (pt) * 2011-08-26 2022-11-22 Takeda Pharmaceutical Company Limited Método para reduzir conteúdo de fator xi e/ou fator xia em uma composição de imunoglobulina
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US8986670B2 (en) 2012-02-29 2015-03-24 Baxter International Inc. IgG stimulated remyelination of peripheral nerves
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
CN104231065A (zh) * 2014-09-09 2014-12-24 青岛康大食品有限公司 兔血中球蛋白的纯化制备方法
WO2017066683A1 (fr) 2015-10-15 2017-04-20 Plasma Technologies, Llc Procédés d'extraction de protéines à partir de plasma sanguin
CA3012694A1 (fr) * 2016-02-03 2017-08-10 Plasma Technologies, Llc Procedes d'extraction de proteines a partir d'un materiau a base de sang
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
MX2022011950A (es) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
DE4118912C1 (fr) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
ES2129076T5 (es) 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
KR100501263B1 (ko) * 1998-06-09 2005-07-18 스태튼스 세룸 인스티튜트 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren

Also Published As

Publication number Publication date
EP1268551A2 (fr) 2003-01-02
PT1268551E (pt) 2004-07-30
US20030143222A1 (en) 2003-07-31
DE60102144T2 (de) 2004-10-28
BR0109740A (pt) 2003-02-04
US6835379B2 (en) 2004-12-28
DE60102144D1 (de) 2004-04-01
RU2002124857A (ru) 2004-02-20
CN1419566A (zh) 2003-05-21
ATE260297T1 (de) 2004-03-15
AU7390701A (en) 2001-10-08
BRPI0109740B8 (pt) 2021-05-25
CA2402784A1 (fr) 2001-10-04
WO2001072844A2 (fr) 2001-10-04
JP2003530326A (ja) 2003-10-14
EP1268551B1 (fr) 2004-02-25
AU2001273907B2 (en) 2006-02-02
WO2001072844A3 (fr) 2002-04-11
TR200400701T4 (tr) 2004-05-21
RU2266914C2 (ru) 2005-12-27
BR0109740B1 (pt) 2015-01-06
IL151667A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
SE0001128D0 (sv) A method of producing IgG
JPH0231689A (ja) 百日咳トキシンの精製法
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
RU2006134285A (ru) Способ получения очищенных, безопасных с вирусологической точки зрения препаратов антител
TW245768B (en) Method for killing microorganisms
FR2737730B1 (fr) Procede de purification de virus par chromatographie
DK1105466T3 (da) Fremgangsmåde til oprensning af humant papillomvirus-viruslignende partikler
ES2136115T3 (es) Enzima formadora de sacaridos no reductores, y su preparacion y usos.
JPS5944320A (ja) Ｃ１不活性化剤の調製方法
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
DK0813541T3 (da) Fremgangsmåde til fremstilling af et protein
SI9420008B (sl) Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje
CA2244095A1 (fr) Procede de production d'un catalyseur pour l'epuration des gaz d'echappement
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
WO2003034982A3 (fr) Procede de purification a rendement eleve d'immuno-globulines a partir de plasma sanguin et d'intermediaires de plasma sanguin
CN1214042C (zh) 静脉内免疫血清球蛋白及其产物的生产方法
ES8505820A1 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
EP1376021A4 (fr) Systeme d'apport d'air, procede de desinfection de l'air, et systeme et procede de transfert
CN1089609C (zh) 从人血浆分部分离过程产生的馏分中回收免疫球蛋白的方法
RU2006118024A (ru) Способ удаления вирусов из жидкой композиции, содержащей фактор vii
CN1181782A (zh) 一种从生物原料中制备因子ix的方法
US20020018985A1 (en) Method for depleting viral and molecular pathogens in a biological material
AT381026B (de) Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
AU726808B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
TWI526214B (zh) 缺乏一種以上致血栓因子的血漿製品之製備方法